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ABSTRACT. Bovine brucellosis is a zoonotic disease that has 
considerable economic impact on the market of products such as 
meat and milk. As Brazil has one of the largest cattle herds in the 
world, this disease is a significant agricultural and public health 
concern. In 2001, Brazil launched the National Program of Control 
and Eradication of Animal Brucellosis and Tuberculosis. This 
program included the vaccination of 3-8 month old calves using the 
smooth and attenuated S19 strain, as well as monitoring with 
serological tests. There have been reports of excretion and persistence 
of S19. In this context, the objective of this study was to monitor the 
persistence of the S19 vaccine strain in blood samples from 
vaccinated calves. Seroconversion was investigated to evaluate the 
vaccine immunogenicity. PCR assays of blood and serum were run at 
at: "day zero" (before vaccination), 1 to 15 days after vaccination and 
every month until 12 months, totaling 28 collections for each of 10 
calves. The vaccine strain was detected throughout the study, even at 
day zero, before the calves were vaccinated. Sequencing analysis 
confirmed the presence of the S19 strain. Results from serological 
tests did not show agglutination in “day zero” samples, meaning the 
immune response was negative. An immune response was first 
detected in two samples on the fourth day. One hypothesis that could 
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explain this positivity before vaccination is that the already 
vaccinated mothers could have transmitted the vaccine to the calves, 
as the cows presented excretion of the S19 strain in milk and/or urine. 
This is the first report of the finding of this bovine brucellosis 
vaccine strain in the blood of calves before vaccination. 
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INTRODUCTION 
 
Brucellosis is an infectious contagious disease caused by the bacteria of the genus 
Brucella spp., affecting various species of animals (de Figueiredo et al., 2015), including 
humans (Hull and Schumaker, 2018). It is considered an emerging and occupational disease 
and is a potential agent for bioterrorism; consequently, it has caught the attention of health 
systems (Lawinsky et al., 2010). Brucella abortus is the main etiological agent of bovine 
brucellosis, a disease that affects reproduction, causes orchitis, and a loss of libido and 
infertility in males (Favero et al., 2008). The main effects in females include abortions, 
resulting in a reduction in milk production (Chand et al., 2015).  
 In addition, this disease also causes the devaluation of animal products and results 
in international barriers, affecting the commercialization of cattle products, leading to great 
economic losses for the country (Jardim et al., 2006; Dias et al., 2009). Bovine brucellosis is 
the most common brucellosis in Brazil (Poester et al., 2002).  
 According to the Brazilian Beef Exporters Association (ABIEC), Brazil has a cattle 
herd of 213.68 million and the amount of beef exported in 2019 was 2.49 million tons, 
12.2% higher than in 2018. Regarding milk production, Brazil produced 33.5 billion liters 
in 2017 (IBGE, 2017).  
 Under these circumstances, the National Program of Control and Eradication of 
Animal Brucellosis and Tuberculosis (PNCEBT) was launched in 2001 by the Ministry of 
Agriculture, Livestock and Food Supply (MAPA). This program was responsible for 
implementing measures such as vaccinating calves aged from 3-8 months, using the S19 
vaccine strain, as well as tests for diagnosis. These tests include Buffered Acidified Plate 
Antigen (BAPA), and milk ring tests as triage tests, and 2-mercaptoethanol (2-ME) and 
Complement Fixation (CF) as confirmatory tests (Brasil, 2006). 
 The S19 vaccine is the most effective vaccine in preventing bovine brucellosis and 
it is characterized as a live attenuated strain (Miranda et al., 2013). This strain was isolated 
from the milk of a Jersey cow and the plaque was forgotten at room temperature for one 
year. After analysis, the loss of virulence was verified (Brasil, 2006).  
Though it has proven effective, this vaccine can infect humans (Osman et al., 2015) 
and induce abortion in pregnant cows (Sangari et al., 2000). Some studies have 
demonstrated persistence and excretion of the S19 vaccine strain. This strain has been found 
in cheese (Miyashiro et al., 2007; Silva et al., 2016; Hérnandez-Carbajan et al., 2018), 
semen (Júnior et al., 2017; Lourencetti et al., 2018; Junqueira-Junior et al., 2018), urine, and 
milk of cows up to nine years of age (Pacheco et al., 2012).  
 False positives in serological tests can occur through cross-reactions with 
pathogens that present antigens similar to those of Brucella spp. (Munoz et al., 2005), as 
well as in animals that were vaccinated with S19. As S19 is a smooth strain, it expresses the 
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O chain in its lipopolysaccharide, making it harder to work out which of the animals are 
actually infected (Sangari et al., 2000). False negative results in serological tests may also 
occur (Júnor et al., 2017; Junqueira-Junior et al., 2018). 
 PCR detection is a fast and accurate method that overcomes the limitations of 
traditional methodologies (Mohamed et al., 2013). It makes it possible to differentiate 
between the wild type and the vaccine strain (Sangari and Agüero, 1994; Bricker and 
Halling, 1995). PCR has been used to detect Brucella spp. in various types of samples. 
 In this context, the objective of this study was to monitor the persistence and 
immunogenicity of the S19 vaccine strain in the blood samples of vaccinated calves. 
MATERIAL AND METHODS 
 
Animal experiments were previously approved by the Ethics Committee for the use 
of Animals at Universidade Federal de Mato Grosso do Sul (protocol no. 555/2013) and 
carried out in accordance with guidelines issued by the Brazilian National Council of 
Animal Experimentation (CONCEA). Ten Brangus breed calves, aged between 6-8 months, 
were randomly selected for immunization against bovine brucellosis in a private property in 
the State of Mato Grosso do Sul. In the 12
th
 month the loss of one calf due to loss of the ID 
tag was reported during sample collection. 
A live attenuated S19 vaccine containing 60 billion viable bacteria per dose was 
used. Two mL of vaccine was administered subcutaneously to the pre-scapular region, 
according to the manufacturer’s instructions. 
Collection, preparation, extraction of the samples and Buffered Acidified Plate 
Antigen 
 
 The blood and serum collections were performed using 5mL vacuum tubes with 
EDTA and without EDTA respectively. The jugular vein was punctured to collect the 





the vaccination and monthly until 12 months, totaling 28 collections and 279 samples 
(because the identification was lost and it wasn’t possible to identify one of the calves). The 
collected blood samples were immediately stored at -20°C until DNA extraction. The tubes 
without EDTA were kept at room temperature until complete separation of the serum, 
which was transferred to a 1.5mL tube and stored until its use in the serological test. 
 The extraction of DNA from the blood was carried out according to the 
methodology proposed by Araújo et al. (2009), with adaptations. 500 μL of 20% SDS and 2 
μL of proteinase K (20 mg/mL) were added into 300 μL of blood, followed by incubation at 
65°C for 1 h. 800 μL of chloroform and 350 μL of protein precipitation solution (potassium 
acetate and glacial acetic acid) were then added, followed by the centrifugation of the 
mixture at 13.000 rpm for 15 min. The supernatant was collected and the DNA precipitation 
was performed by adding 1 mL of ice-cold absolute ethanol. Negative controls were 
performed in all the extractions to ensure non-contamination and no laboratory artifact 
throughout the process. 
 Readings at wavelengths of 260 and 280 nm using NanoDrop 2000 equipment 
(Thermo Fisher Scientific Corporation, USA) were performed to measure the quantity and 
quality of the samples. All the samples were adjusted to a concentration of 100 ng/uL and 
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then analyzed using 0.8% agarose gel, stained with SYBR Gold (Invitrogen-Thermo Fisher 
Scientific Corporation, USA) and further visualized in an ultraviolet translucent. 
 The Buffered Acidified Plate Antigen (BAPA) serological test was performed in 
the serum samples until the seroconversion according National Program of Control and 
Eradication of Animal Brucellosis and Tuberculosis (PNCEBT) 
Polymerase Chain Reaction and Sequencing   
 
 A pair of primers adapted from the multiplex PCR called Bruce-Ladder (García-
Yoldi et al., 2006) were used to identify the Brucella spp. The primers selected were 
BMEII0535f (5 'GCG CAT TCT TCG GTT ATG AA 3') and BMEII0536r (5 'CGC AGG 
CGA AAA CAG CTA TAA 3'), which amplify a 450 bp fragment related to the bp26 gene 
encoding an immunodominant antigen (this gene has an 870 bp insert in B. pinnipedialis 
and B. ceti species). 
 The reaction was carried out in a final volume of 20 μL containing: 9.7 μL of 
ultrapure water; 2 μL of Buffer (10X); 0.6 μL of MgCl2 (50 mM); 0.3 μL of taq DNA 
polymerase (5 U/μL) (Invitrogen-Thermo Fisher Scientific Corporation, USA); 1 μL of each 
primer (5 pMol); 0.4 μL of DNTPs (10 mM) (Sigma Aldrich, USA) and 5 μL of DNA (100 
ng/uL). The amplification was performed using the Veriti 96-well Thermal Cycler (Applied 
Biosystems, USA) with the following parameters: initial denaturation at 95ºC for 7 min, 
followed by 35 cycles at 95ºC for 35 s, hybridization at 54ºC for 45 s and an extension at 
72°C for 3 min, followed by a final extension at 72°C for 7 min. All PCR were performed 
with negative control to ensure non-contamination and no laboratory artifact. 
 The primers Eri1 (5 'TTG-GCG-GCA-AGT-CCG-TCG-GT 3') and Eri2 (5 'CCC-
AGA-AGC- AAA-CG 3 ') described by Sangari et al. (1994) were used to differentiate the 
vaccine strain with the wild-type strain. These primers were designed to amplify a gene 
related to erythritol catabolism, which contained a 1063 bp fragment in the wild strain and a 
361 bp in the S19 vaccine strain, due to a 702 bp deletion in the latter. This PCR was 
performed in the samples that had tested positive for the primers BMEII0535f and 




after vaccination periods, and also in the 
S19 vaccine strain as positive control, for subsequent sequencing. 
 The 20 μL final reaction volume contained: 9.5 μL of ultrapure water; 2 μL of 
Buffer (10X); 0.6 μL of MgCl2 (50 mM); 0.3 μL of taq DNA polymerase (5 U/μL) 
(Invitrogen-Thermo Fisher Scientific Corporation, USA); 1 μL of each primer (5 pMol); 0.6 
μL of DNTPs (10 mM) (Sigma Aldrich, USA) and 5 μL of DNA (100 ng/uL). The 
amplification was performed using a Veriti 96 Well Thermal Cycler (Applied Biosystems, 
USA) with the following parameters: initial denaturation at 94°C for 10 min, followed by 
35 cycles at 94°C for 1 min, hybridization at 57°C for 2 min, and an extension at 72°C for 2 
min, followed by a final extension at 72ºC for 10 min. All PCR were performed with 
negative control to ensure non-contamination and no laboratory artifact. 
 The PCR products analysed in a 1.5% agarose gel electrophoresis. The resulting 
bands of the gel were developed using ethidium bromide in UV light illumination. The 
reference molecular weight used was 1 kb plus DNA ladder (Invitrogen - Thermo Fisher 
Scientific Corporation, USA). 
 To confirm the PCR results, the targeted bands from the “day zero” and the 12
th
 
month after vaccination obtained using both primers pair were excised from the agarose gel 
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and purified. The purification was performed using a homemade protocol by using a 1mL 
tip with a filter, followed by an addition of sodium acetate and absolute ethanol for the 
precipitation of the DNA. The DNA was then resuspended in 20 μL of ultrapure water. 
After purification, the samples from each PCR were placed together forming two pools for 
sequencing. 
 The sequencing reactions were performed using a MicroAmp Fast Optical 96-well 
Reaction Plate with Barcode (Applied Biosystems, USA). Each well contained a final 
volume amounting to 10 μL consisting of: 0.5 μL of BigDye®Xterminator™, 2 uL of 
SAM™Solution (Applied Biosystems, EUA), 50 ng of the purified PCR products and 0.64 
μL of the respective primer pairs used previously (5 pmol/μL). In a Veriti 96-well thermal 
cycler (Applied Biosystems), these mixtures were submitted to initial denaturation at 96°C 
for 1 min, followed by 25 cycles at 96°C for 10 s, hybridization at 50°C for 5 s and an 
extension at 60°C for 4 min. EDTA and absolute ethanol were added, followed by 15 min at 
room temperature and centrifugation at 5.700 rpm for 15 min at a temperature of 4°C. After 
that, 10 μL of Formamide HI-DI was added to the pellet. 
 A denaturation was performed at 94°C for 3 min in the Veriti 96-well thermal 
cycler model (Applied Biosystems, USA), and a heat shock was performed by immediate 
cooling of the samples on ice. The sequencing was performed using ABI 3130XL 
equipment (Applied Biosystems, USA) based on the Sanger method. All the results were 
analyzed by BLASTn (Basic Local Alignment Search Tool) and the sequencing obtained 
with Eri1 and Eri2 it was also aligned with the results from the positive control, S19 vaccine 
strain, using the software Mega 5.02. 
RESULTS AND DISCUSSION 
 
The application of the PCR technique using the pair of primers BMEI0535f and 
BMEI0536r in the 279 samples (28 collections from each calf over a year) generated 
positive results throughout the period, including the "day zero" samples. The 450 bp bands 
showed the presence of genetic material from Brucella spp., and the absence of 
amplification in the negative controls proved that there was no contamination from 
laboratory artifacts or from manipulation (Figure 1). These results demonstrated that this 
bacterium remained circulating in the bloodstream throughout the period of study. 
 The PCR using the pair of primers ERI1 and ERI2 was performed in the 19 
samples collected on the "day zero" and on the 12
th
 month after vaccination, to identify the 
differences between the wild type and the vaccine strain. The 361 bp bands confirmed the 
presence of the vaccine strain. The presence of wild strain would have only been 
demonstrated with the presence of bands at 1063 bp. These data showed that the S19 strains 
were circulating in the bloodstream for one year; this strain was already present in the 
calves before vaccination.   
The sequencing was carried out using the same 19 samples (day zero and 12
th
 
month after vaccination) to identify the amplified fragments using the primers BMEI0535f 
and BMEI0536r (450 pb) and Eri1 and Eri2 (361pb). The comparison between the results of 
the sequencing to the NCBI database using the BLASTn search program was performed 
using Megablast (Highly similar sequences), confirming our earlier results. Brucella spp. 
presented a total score of 67.6, an e-value of 1e-07 and a 90.38% similarity to the “Brucella 
abortus RB51 – AHVLA strain RB51chromossome I, complete sequence” (access 
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CP046720.1). The total score of the sequence obtained from the Eri1 and Eri2 PCR was 
374, with an e-value of 2e-99 and 100% identity with "B. abortus S19 chromosome 2, 
complete sequence" (access CP000888.1). In addition, the alignment between the 
sequences from the samples and the positive control of the vaccine strain using Mega-X 
software, once again, confirmed the presence of the S19 vaccine strain (Figure 
Supplementary 1 and Figure Supplementary 2). 
 
 
Figure 1. Amplification of a 450 bp fragment using the pair of primers BMEII0535f/BMEII0536r to detect genus 
Brucella spp. 1.5% agarose gel stained with ethidium bromide. Application of 20 µL of PCR using the pair of 
primers BMEII0535f and BMEII0536r in the 6
th 
month samples. Lines 1-10: all the 6
th 
month samples from 
calves, line 11: positive control, line 12: reference molecular weight 1 kb plus DNA ladder (Invitrogen - 
Thermo Fisher Scientific Corporation, USA), line 13: negative control, and lines 14-15: negative control of 
extraction. 
 
Serological results using the Buffered Acidified Plate Antigen (BAPA) showed 
no immune response in the “day zero” samples, which was demonstrated by the absence 
of agglutination. The samples remained negative until the third day after vaccination. 
Two positive samples were observed on the fourth day, increasing to eight on the fifth 




Vaccinations are crucial to the National Program for Control and Eradication of 
Animal Brucellosis and Tuberculosis (PNCEBT). An effective vaccine induces protective 
immunity without causing pathogenicity (Sadanand, 2011). The vaccination with S19 
induces a strong serological response that persists for a few months and reduces 
significantly over time. However, some animals can maintain this induction longer 
(Blankenheim et al., 2015). PNCEBT recommends performing serological tests only when 
the animal reaches 24 months of age (Brasil, 2006). 
 The possibility of false positives in serological tests has been investigated and 
discussed in great detail. Junqueira Junior et al. (2017) highlighted the importance to 
consider the occurrence of false negative results. Out of 27 samples of bovine semen, two 
animals with negative serological tests presented the wild strain after analysis by PCR, 
demonstrating how effective this technique is at detecting genetic material of Brucella spp. 
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In addition, the same research group detected 14 positive samples for the vaccine strain by 
PCR, of which five also contained the DNA of wild-type B. abortus. Similar results were 
obtained by Lourencetti et al. (2018) who identified 68 semen samples contaminated with 
S19 from a total of 100 by using PCR, however no serum sample from the same cattle was 
positive when using the Rose Bengal test (RBT). According to Júnior et al. (2017), bovine 
brucellosis diagnosis based only in serological tests probably underestimates infection 
caused by B. abortus in bulls. The authors submitted 335 serum and semen samples to 
serological tests and PCR analyses, and identified five bulls positive in the conventional 
RBT, (2-ME), semen plasma agglutination (SPA), modified 2-ME, microbiological culture 
in Farrell media, and the detection of B. abortus strain S19 by PCR. Two bulls presented 
negative results in all the serodiagnosis tests but were positive by PCR for B. abortus field 
strain. Therefore, the authors indicated the inclusion of molecular methods to improve the 
diagnosis in bovine bulls. The data from these studies were similar to our results, which 
presented negative BAPA tests in the “day zero” serum samples, even with the presence of 
the S19 strain detected by PCR and confirmed by sequencing.  
 Although vaccination is restricted to females, the presence of S19 in semen can be 
explained through the wrong vaccination of males (Júnior et al., 2017) or contamination of 
the environment by the vaccinated cows. The cows could infect the environment with S19 
through excretion and therefore contaminate the males (Júnior et al., 2017; Junqueira Junior 
et al., 2018). This contamination of the environment by the S19 may also explain the 
findings from a study conducted in North Carolina. This study detected S19 in 10% of 80 
wild pigs that were in an area with no cattle since 1970 (Stoffegen et al., 2007).  
 Studies were carried out to evaluate longer excretion periods of the vaccine strain 
in vaccinated cows between the ages of 3-9 years, in a complete reproductive cycle. The 
results showed that the excretion mainly occurs up until the 150
th
 day of pregnancy, during 
and after labor. This was confirmed by analyzing the milk and urine of the cows, with the 
latter being the main source of excretion (Pacheco et al., 2012). Miyashiro et al. (2007) 
evaluated 192 illegally produced cheeses from the states of São Paulo and Minas Gerais, 
and found that 37 of them tested positive for the genus Brucella spp., 30 out of the 37 
(81.08%), presented S19, demonstrating that this strain can be excreted in milk. The 
presence of S19 in cheese was also reported by Silva et al (2016) and Hérnández-Carbajal et 
al (2018).  
 The contamination of humans by S19 vaccine was confirmed by the isolation of 
this strain in the blood samples of the milkers (Osman et al., 2015). The transmission of a 
live strain used as a vaccine was evaluated by Kojouri and Gholami (2009). PCR analyses 
were carried out using blood samples from vaccinated sheep (n = 10) with the live vaccine 
strain Rev1, and from non-vaccinated sheep (n = 5). The live vaccine strain Rev1 is used for 
immunization against B. melitensis. On the 14
th
 day after vaccination, 40% of the sheep in 
the non-vaccinated group showed positive PCR results, and serological tests showed that 
both groups (vaccinated and unvaccinated) presented antibodies against Brucella spp.  
 The main known difference between the wild-type strain and the S19 vaccine strain 
is the metabolism of erythritol. The latter does not contain the enzyme D-erythrose-1-
phosphate dehydrogenase, which is essential for the catabolism of this polyalcohol. This 
results in the accumulation of intermediate toxic products (D-erythrose 1-phosphate) and a 
reduction of the ATP, which inhibits the growth of S19 (Sperry and Robertson, 1975). On 
the other hand, erythritol could be responsible for the growth and presence of B. abortus in 
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the placenta, and in other fetal tissues of pregnant cows (Smith et a., 1962). In addition, 
some mutant strains of S19 presented tolerance to erythritol and can cause a miscarriage and 
/ or persistence when inoculated with the administration of the S19 strain vaccine (Sangari 
et al., 1996).  
 The persistent excretion of the S19 vaccine strain may explain the results obtained 
with the calves in this study. The presence of this strain in calves before being vaccinated 
could be the result of contact with their mothers, which already presented the vaccine 
strains in their urine and / or milk. This fact along with the ability of the S19 strain to 
contaminate the environment, as well as the capacity of vaccine strains to be transmitted 
between the animals can explain our findings.  
 This is the first study that showed a bovine brucellosis vaccine strain presented in 
the blood of calves before vaccination. Further study is essential to understand the presence 
of S19 vaccine and how it leads to the contamination of the environment, its possible 
transmission capacity between cattle and other species, including humans, as well as the 
epidemiological importance of this process. Furthermore, the use of only serological tests 
could have underestimated the infection or presence of Brucella spp. The molecular 
techniques are growing within the scope of testing and both methods could be used together 
to improve the diagnosis of brucellosis. 
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